Adenovirus Vaccine Pregnancy Registry

Withdrawn before enrolling

Conditions studied: Adenovirus

In brief

The primary purpose of the Adenovirus Vaccine Pregnancy Registry is to prospectively collect data concerning: 1. Pregnant women exposed to Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, 2. Potential confounding factors, and 3. The outcome of these pregnancies. The secondary purpose of the Adenovirus Vaccine Pregnancy Registry is to evaluate the frequency of birth defects in prospectively enrolled pregnant women. This Registry is also designed to detect any unusual patterns of birth defects.

Key facts

Study ID
NCT01584037
Run by
Teva Branded Pharmaceutical Products R&D, Inc.
People needed
0
Starts
2011-12-01
Expected to finish
2014-04-01
Last updated by the study team
2014-04-21

Who can join

Age: 17 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.